ADD, ADHD
Conditions
Keywords
tdcs, tms, qeeg, neuroplasticity, brain networks, add, adhs
Brief summary
In the present study the aim is to examine whether transcranial direct-current stimulation (tDCS) generated excitability changes and induce modifications of functional cortical architecture in Attention Deficit Hyperactivity Disorder (ADHD) patients. To achieve this, the investigators used an event-related potential (ERP) analysis based on 20 channel EEG recordings in ADHD subjects before and after bipolar tDCS-anode stimulation over F3/F4 or T5/T6 or P4/P3, during resting state and measure clinical scores and visual CPT tasks changes. Time courses and topography of independent component visual ERPs were compared before and after tDCS.
Detailed description
Important advances in the understanding of ADHD pathophysiology, such fMRI studies showing a focal frontotemporal loops dysfunction in brain activity, suggest that frontal brain stimulation might be helpful for the treatment of ADHD. In a recent study of Lyon's university with tDCS they concluded that tDCS is cheaper and easier-use than transcranial magnetic stimulation (TMS) and the impact on symptomatology seems larger (impact on negative symptoms of schizophrenic patients) and longer (at least 3 months duration) than that TMS currently permits. It is possible that tDCS could in the future be used at home by patients themselves. The efficacy of tDCS depends of parameters like electrode position and current strength. In this trial, The investigators investigated the effects of 12 days of anodal stimulation of the left dorsolateral prefrontal cortex in ten patients with ADHD (aged 8 +/- 3 years). tDCS was applied through a saline-soaked pair of surface sponge electrodes (35 cm2). The anode electrode was placed over F3/F4 or T5/T6 or P4/P3(based on the 10-20 International EEG System) of each subject. The cathode was placed over the contralateral mastoid area. A constant current between 1.1 and 2.0 mA was applied for 25 min/day (administered for 12 alternated days). Prior to the first session, ADHD subjects were asked to complete and return a series of questionnaires, including the Conners Brief Symptom Inventory, a health history questionnaire, and the QEEG questionnaire. Subjects were then tested in a first session which lasted approximately three hours. During this period, a comprehensive structured clinical interview was carried out, comprising of an assessment of current and past ADHD symptoms, the history of problems at school, the past psychiatric history (including drug and medication use), as well as past and present comorbidities. Subsequently, EEG data was acquired. EEG data was first recorded while the subject was in eyes-closed and eyes-open resting conditions, lasting four minutes each. Then data was recorded while subjects performed a visual continuous performance task (VCPT). The VCPT took approximately 22 minutes to complete. In addition, subjects randomly performed either an auditory or an emotional continuous performance task. The control group had a shortened procedure. Subjects were tested in a single session lasting approximately two and a half hours. During this period, a series of questionnaires (Brief Symptom Inventory, Health History questionnaire, Current Symptoms Scales) were filled out and thereafter, EEG data was acquired. Subsequently, a working memory task, which is not relevant here, was administered. EEG was recorded using a Mitsar 201 19-channel electroencephalographic system. The input signals referenced to the linked ears were filtered between 0.5 and 50 Hz and digitized at a sampling rate of 250 Hz. Impedance was kept below 5 kOhm for all electrodes. Electrodes were placed according to the International 10-20 system using a electrode cap. Quantitative data was calculated using WinEEG software. Linked ears reference montage was changed to average reference montage prior to data processing. Eye-blink artefacts were corrected by zeroing the activation curves of individual ICA component score responding to eye blinks. In addition, epochs of the filtered electroencephalogram with excessive amplitude (\>100 μV) and/or excessive fast (\>35 μV in 20 to 35 Hz band) and slow (\>50 μV in 0 to 1 Hz band) activity were automatically marked and excluded from further analysis. Finally, EEG was manually inspected to verify artefact removal. Behavioral task The VCPT is a modification of the visual two-stimulus GO/NOGO paradigm. Three categories of visual stimuli were selected: 20 pictures of animals, 20 pictures of plants, and 20 pictures of humans (presented together with an artificial novel sound). The trials consisted of presentations of pairs of stimuli: animal-animal (GO trials), animal-plant (NOGO trials), plant-plant (IGNORE trials), and plant-human (NOVEL trials). The trials were grouped into four blocks. In each block a unique set of five animal stimuli, five plant stimuli and five human stimuli was selected. Each block consisted of a pseudo-random presentation of 100 stimuli pairs with equal probability for each trial category. The task was to press a button as fast as possible in response to GO trials. According to the task design, two preparatory sets were distinguished in the trials. In the Continue set a picture of an animal is presented as the first stimulus and the subject is supposed to prepare to respond. In the Discontinue set a picture of a plant is presented as the first stimulus and the subject does not need to prepare to respond. During the task, subjects were seated in a comfortable chair, 1.5 m in front of a computer screen. The stimuli were presented on a 17 inch monitor using the Psytask (Mitsar Ltd.) software. The primary outcome was change in score on the QEEG Rating Scale (AMEN questionnaire). The ERP and questionnaire/behavioural assessments will be made at baseline (before stimulation)and 3 months after stimulation. This study involved 30 subjects, all aged between 7 and 13. All have been diagnosed with ADHD by a medical professional.
Interventions
tDCS applied to left dorsolateral prefrontal scalp area through a saline-soaked pair of surface sponge electrodes (35 cm2). The anode electrode was placed over F3 (based on the 10-20 International EEG System) of each subject. The cathode was placed over the contralateral mastoid area. A constant current of 1.1 mA was applied for 25 min/day (administered for 12 alternated days).
Sponsors
Study design
Eligibility
Inclusion criteria
1. ADHD diagnosis. 2. Age between 7 and 65 years. 3. Comorbidities were no reason for subject exclusion.
Exclusion criteria
1. Presence of psychosis. 2. Subjects taking medication,they had refrained from taking methylphenidate during 24 hours before testing. 3. Subjects taking other psychotropics were not included in the study. 4. Subjects which had suffered of a head injury with subsequent loss of consciousness, and subjects suffering from neurological or systemic medical diseases were excluded from the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinical Assessment (Amen Questionnaire) | From September to December 2012 | The Amen Attention Deficit Disorder (ADD) Type Questionnaire is a 71-question self-test that evaluates the ADD syndrome. 0 never, 1 rarely, 2 Occasionally, 3 Often and 4 Very Often. Consists of a series of questions that evaluate five brain systems: basal ganglia (23 items), Cingular System (17 items), Temporal System (16 items), Prefrontal Cortex (24 items) and deep limbic system (20 items). Each system has a maximum score of 4, and if this punctuation is greater than 1.7 it is possible that the system is deviated from normality and implicated in AD/HD behavior. The minimal average score is 5 (Best) and the maximum is 20 (Worst). More than four is suspicious of diagnosis, six or more of a score of three or four is needed to make diagnosis. Meets the criteria for inattentiveness (six or more on questions 1-14) and also scores six or more on the cingular system questions (24-36 items), over-focused ADD subtype is suspected. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Event-related Potentials Amplitude (ERPs) | From September to December 2012 | ERPs to the GO/NOGO task will be examined for changes as a result of treatment. Assessments were made at baseline (before stimulation), after the 10-12 days of stimulation, and at 1 and 3 months after stimulation. Event related potentials (ERP) generated from a visual continuous performance task (VCPT) are employed to access the early stages of information processing (Mueller et al., 2011; Kropotov, 2008) and performing at a GO/NOGO paradigm may be used to study the mechanisms of the brain's executive functions (Falkenstein et al., 1995). Amplitude and latency of ERP activity recorded from a subject can be compared to normalized databases to predict a possible hyper or hypo function of cerebral circuits. These ERP were recorded on 19 separeted channels according international 10-20 system. Electrode names are derived by brain lobule which is is located below and position, e.g., Pz is Parietal on position zero (midline) and Cz is Central Midline. |
| Event-related Potentials Latency (ERPs) | From September to December 2012 | ERPs to the GO/NOGO task will be examined for changes as a result of treatment. Assessments were made at baseline (before stimulation), after the 10-12 days of stimulation, and at 1 and 3 months after stimulation. Event related potentials (ERP) generated from a visual continuous performance task (VCPT) are employed to access the early stages of information processing (Mueller et al., 2011; Kropotov, 2008) and performing at a GO/NOGO paradigm may be used to study the mechanisms of the brain's executive functions (Falkenstein et al., 1995). Amplitude and latency of ERP activity recorded from a subject can be compared to normalized databases to predict a possible hyper or hypo function of cerebral circuits. These ERP were recorded on 19 separeted channels according international 10-20 system. Electrode names are derived by brain lobule which is is located below and position, e.g., Pz is Parietal on position zero (midline) and Cz is Central Midline. |
| Reaction Time (Behavior Task) | From September to December 2012 | All subjects performed a Visual continuous performance task (VCPT) with GO/NOGO paradigm. It consists of three types of stimuli: 1) twenty animals (A), 2) twenty images of different plant (P), 3) Twenty images of people of different professions (H) which is present with an artificial sound called Novel 20msec and.Thus, each pair of stimulus is presented for 100 milliseconds, at intervals of one second of duration between each block. The objective of is to press a button as quickly as possible while observing the pairs AA, situation called GO, while trying not to press when observes other types of pairs. This latency of response (reaction time) was mensured. Pairs are called GO(AA) NOGO(AP), IGNORE(PP) and NOVEL(PH + Sound). Errors by omission (lack of response in test GO) and by commission (lack of suppression in NOGO test) were be automatically counted for each subject. |
| Number of Omission and Commission Errors of Behavior Task | From September to December 2012 | After VCPT task, errors by Omission (lack of response in test GO) and by commission (lack of suppression in NOGO and NOVELTY test) were automatically counted for each subject. |
Countries
United Kingdom
Participant flow
Recruitment details
Subjects were screened and enrolled at 3 clinics in Spain
Participants by arm
| Arm | Count |
|---|---|
| Active tDCS Transcranial Direct-Current Stimulation. Patients with ADHD that receive electro-stimulation 20 sessions with 2 mAmp 1 session per day alternative days | 30 |
| Controls Healthy people that not receive tDCS | 30 |
| Total | 60 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Physician Decision | 2 | 0 |
Baseline characteristics
| Characteristic | Controls | Active tDCS | Total |
|---|---|---|---|
| Age, Categorical <=18 years | 14 Participants | 19 Participants | 33 Participants |
| Age, Categorical >=65 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical Between 18 and 65 years | 16 Participants | 11 Participants | 27 Participants |
| Age, Continuous | 33.12 years STANDARD_DEVIATION 22.8 | 20.06 years STANDARD_DEVIATION 13.03 | 25.14 years STANDARD_DEVIATION 18.09 |
| Region of Enrollment Spain | 30 participants | 30 participants | 60 participants |
| Sex: Female, Male Female | 12 Participants | 9 Participants | 21 Participants |
| Sex: Female, Male Male | 18 Participants | 21 Participants | 39 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 3 / 30 | 0 / 30 |
| serious Total, serious adverse events | 0 / 30 | 0 / 30 |
Outcome results
Clinical Assessment (Amen Questionnaire)
The Amen Attention Deficit Disorder (ADD) Type Questionnaire is a 71-question self-test that evaluates the ADD syndrome. 0 never, 1 rarely, 2 Occasionally, 3 Often and 4 Very Often. Consists of a series of questions that evaluate five brain systems: basal ganglia (23 items), Cingular System (17 items), Temporal System (16 items), Prefrontal Cortex (24 items) and deep limbic system (20 items). Each system has a maximum score of 4, and if this punctuation is greater than 1.7 it is possible that the system is deviated from normality and implicated in AD/HD behavior. The minimal average score is 5 (Best) and the maximum is 20 (Worst). More than four is suspicious of diagnosis, six or more of a score of three or four is needed to make diagnosis. Meets the criteria for inattentiveness (six or more on questions 1-14) and also scores six or more on the cingular system questions (24-36 items), over-focused ADD subtype is suspected.
Time frame: From September to December 2012
Population: The number of participants needed for study completion is between 20 and 40 for pilot study if it is homogeneous in patients with clinical signs and symptoms, to test efficacy and safety of noninvasive Brain Stimulation.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Active tDCS | Clinical Assessment (Amen Questionnaire) | Amen Average Scale Pre_tDCS | 9.85 units on a scale | Standard Deviation 1.55 |
| Active tDCS | Clinical Assessment (Amen Questionnaire) | Amen Average Scale Post_tDCS at 3 months | 5.15 units on a scale | Standard Deviation 1.83 |
| Control Group | Clinical Assessment (Amen Questionnaire) | Amen Average Scale Pre_tDCS | 3.55 units on a scale | Standard Deviation 1.2 |
| Control Group | Clinical Assessment (Amen Questionnaire) | Amen Average Scale Post_tDCS at 3 months | 3.54 units on a scale | Standard Deviation 1.21 |
Event-related Potentials Amplitude (ERPs)
ERPs to the GO/NOGO task will be examined for changes as a result of treatment. Assessments were made at baseline (before stimulation), after the 10-12 days of stimulation, and at 1 and 3 months after stimulation. Event related potentials (ERP) generated from a visual continuous performance task (VCPT) are employed to access the early stages of information processing (Mueller et al., 2011; Kropotov, 2008) and performing at a GO/NOGO paradigm may be used to study the mechanisms of the brain's executive functions (Falkenstein et al., 1995). Amplitude and latency of ERP activity recorded from a subject can be compared to normalized databases to predict a possible hyper or hypo function of cerebral circuits. These ERP were recorded on 19 separeted channels according international 10-20 system. Electrode names are derived by brain lobule which is is located below and position, e.g., Pz is Parietal on position zero (midline) and Cz is Central Midline.
Time frame: From September to December 2012
Population: The number of participants needed for study completion is between 20 and 40 for pilot study if it is homogeneous in patients with clinical signs and symptoms, to test efficacy and safety of noninvasive Brain Stimulation.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Active tDCS | Event-related Potentials Amplitude (ERPs) | Pz GO amplitude | 6.07 microVolts | Standard Deviation 2.2 |
| Active tDCS | Event-related Potentials Amplitude (ERPs) | Cz NOGO amplitude | 9.22 microVolts | Standard Deviation 3.59 |
| Control Group | Event-related Potentials Amplitude (ERPs) | Cz NOGO amplitude | 7.01 microVolts | Standard Deviation 4.52 |
| Control Group | Event-related Potentials Amplitude (ERPs) | Pz GO amplitude | 5.40 microVolts | Standard Deviation 2.28 |
| Active tDCS at 3 Months | Event-related Potentials Amplitude (ERPs) | Pz GO amplitude | 4.96 microVolts | Standard Deviation 2.28 |
| Active tDCS at 3 Months | Event-related Potentials Amplitude (ERPs) | Cz NOGO amplitude | 7.23 microVolts | Standard Deviation 2.49 |
| Controls at 3 Months | Event-related Potentials Amplitude (ERPs) | Pz GO amplitude | 4.77 microVolts | Standard Deviation 2.12 |
| Controls at 3 Months | Event-related Potentials Amplitude (ERPs) | Cz NOGO amplitude | 7.21 microVolts | Standard Deviation 2.19 |
Event-related Potentials Latency (ERPs)
ERPs to the GO/NOGO task will be examined for changes as a result of treatment. Assessments were made at baseline (before stimulation), after the 10-12 days of stimulation, and at 1 and 3 months after stimulation. Event related potentials (ERP) generated from a visual continuous performance task (VCPT) are employed to access the early stages of information processing (Mueller et al., 2011; Kropotov, 2008) and performing at a GO/NOGO paradigm may be used to study the mechanisms of the brain's executive functions (Falkenstein et al., 1995). Amplitude and latency of ERP activity recorded from a subject can be compared to normalized databases to predict a possible hyper or hypo function of cerebral circuits. These ERP were recorded on 19 separeted channels according international 10-20 system. Electrode names are derived by brain lobule which is is located below and position, e.g., Pz is Parietal on position zero (midline) and Cz is Central Midline.
Time frame: From September to December 2012
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Active tDCS | Event-related Potentials Latency (ERPs) | Pz GO latency | 323.78 milliseconds | Standard Deviation 10.6 |
| Active tDCS | Event-related Potentials Latency (ERPs) | Cz NOGO latency | 348.67 milliseconds | Standard Deviation 17.89 |
| Control Group | Event-related Potentials Latency (ERPs) | Cz NOGO latency | 354.00 milliseconds | Standard Deviation 15.17 |
| Control Group | Event-related Potentials Latency (ERPs) | Pz GO latency | 324.44 milliseconds | Standard Deviation 16.49 |
| Active tDCS at 3 Months | Event-related Potentials Latency (ERPs) | Pz GO latency | 321.56 milliseconds | Standard Deviation 13.33 |
| Active tDCS at 3 Months | Event-related Potentials Latency (ERPs) | Cz NOGO latency | 348.22 milliseconds | Standard Deviation 16.38 |
| Controls at 3 Months | Event-related Potentials Latency (ERPs) | Pz GO latency | 326.21 milliseconds | Standard Deviation 15.11 |
| Controls at 3 Months | Event-related Potentials Latency (ERPs) | Cz NOGO latency | 352.17 milliseconds | Standard Deviation 14.91 |
Number of Omission and Commission Errors of Behavior Task
After VCPT task, errors by Omission (lack of response in test GO) and by commission (lack of suppression in NOGO and NOVELTY test) were automatically counted for each subject.
Time frame: From September to December 2012
Population: The number of participants needed for study completion is between 20 and 40 for pilot study if it is homogeneous in patients with clinical signs and symptoms, to test efficacy and safety of noninvasive Brain Stimulation.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Active tDCS | Number of Omission and Commission Errors of Behavior Task | Omission Errors pre tDCS GO cues | 11.22 Number of omission and commision errors | Standard Deviation 10.64 |
| Active tDCS | Number of Omission and Commission Errors of Behavior Task | Omission Errors post tDCS at 3 months GO cues | 12.22 Number of omission and commision errors | Standard Deviation 16.54 |
| Active tDCS | Number of Omission and Commission Errors of Behavior Task | Comission Errors pre tDCS NOGO cues | 0.83 Number of omission and commision errors | Standard Deviation 3.34 |
| Active tDCS | Number of Omission and Commission Errors of Behavior Task | Comission Errosr post tDCS at 3 months NOGO cues | 0.30 Number of omission and commision errors | Standard Deviation 1.02 |
| Control Group | Number of Omission and Commission Errors of Behavior Task | Comission Errosr post tDCS at 3 months NOGO cues | 0.04 Number of omission and commision errors | Standard Deviation 0.19 |
| Control Group | Number of Omission and Commission Errors of Behavior Task | Omission Errors pre tDCS GO cues | 1.07 Number of omission and commision errors | Standard Deviation 1.27 |
| Control Group | Number of Omission and Commission Errors of Behavior Task | Comission Errors pre tDCS NOGO cues | 0.04 Number of omission and commision errors | Standard Deviation 0.19 |
| Control Group | Number of Omission and Commission Errors of Behavior Task | Omission Errors post tDCS at 3 months GO cues | 1.04 Number of omission and commision errors | Standard Deviation 1.29 |
Reaction Time (Behavior Task)
All subjects performed a Visual continuous performance task (VCPT) with GO/NOGO paradigm. It consists of three types of stimuli: 1) twenty animals (A), 2) twenty images of different plant (P), 3) Twenty images of people of different professions (H) which is present with an artificial sound called Novel 20msec and.Thus, each pair of stimulus is presented for 100 milliseconds, at intervals of one second of duration between each block. The objective of is to press a button as quickly as possible while observing the pairs AA, situation called GO, while trying not to press when observes other types of pairs. This latency of response (reaction time) was mensured. Pairs are called GO(AA) NOGO(AP), IGNORE(PP) and NOVEL(PH + Sound). Errors by omission (lack of response in test GO) and by commission (lack of suppression in NOGO test) were be automatically counted for each subject.
Time frame: From September to December 2012
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Active tDCS | Reaction Time (Behavior Task) | Reaction time after tDCS | 467.04 milliseconds | Standard Deviation 124.44 |
| Active tDCS | Reaction Time (Behavior Task) | Reaction Time Before tDCS | 466.95 milliseconds | Standard Deviation 109.7 |
| Control Group | Reaction Time (Behavior Task) | Reaction Time Before tDCS | 354.68 milliseconds | Standard Deviation 39.02 |
| Control Group | Reaction Time (Behavior Task) | Reaction time after tDCS | 352.29 milliseconds | Standard Deviation 35.49 |
| Active tDCS at 3 Months | Reaction Time (Behavior Task) | Reaction Time Before tDCS | 444.65 milliseconds | Standard Deviation 110.56 |
| Active tDCS at 3 Months | Reaction Time (Behavior Task) | Reaction time after tDCS | 412.49 milliseconds | Standard Deviation 98.41 |
| Controls at 3 Months | Reaction Time (Behavior Task) | Reaction time after tDCS | 351.27 milliseconds | Standard Deviation 35.02 |
| Controls at 3 Months | Reaction Time (Behavior Task) | Reaction Time Before tDCS | 356.58 milliseconds | Standard Deviation 40.01 |